Head-to-head · WeighScore
Embody vs OurView Health
By GLP-1 ScorecardUpdated
Score comparison
Embody has the higher recorded score — 76.5/100 to 67.6/100.
Embody grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Embody is a low-cost injection option, but the modest prepaid savings deserve a close look beside its payment-finality and renewal rules.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Embody | OurView Health |
|---|---|---|
| WeighScore | 76.5/100 | 67.6/100 |
| Grade | C | C |
| Site position | #52 | #181 |
| Semaglutide | $79/mo (one-month injection; $828 annual prepay equals $69/mo) | $75/mo (starting dose, compounded) |
| Tirzepatide | $129/mo (one-month injection; $1,428 annual prepay equals $119/mo) | $135/mo (starting dose, compounded) |
| Coverage | State eligibility not fully published; confirm your location | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #52 · C
Strengths
- One-month injection offers at $79 semaglutide and $129 tirzepatide
- Separate monthly, three-, six- and twelve-month price tiers published
- OpenLoop care network and four pharmacy partners publicly named; individual assignment still needs confirmation
What to consider
- Payments are described as final at purchase except provider-initiated medical disqualification, with used services deducted
- Cancel at least 72 hours before renewal; unused prepaid months are not routinely refundable
- Homepage week counts differ from product month labels; confirm supply and charge dates
- Current catalog supports injections; no active oral-gum offer or universal state footprint confirmed
Site position #181 · C
Strengths
- Low starting prices via the Savings Club — compounded semaglutide from $75, tirzepatide from $135
- Clear product pricing with no contracts; medication shipped to your door (30-day supply)
- Full legal suite published (Terms, Privacy, HIPAA Notice, Returns & Refunds)
- Discloses meds are compounded by a licensed third-party pharmacy; multi-vertical (TRT, HRT, BHRT, peptides)
What to consider
- A comparison table on the site quotes $90 'without membership' against $75 'with membership' while the product cards say 'No membership' and the cart charges $75 without one — the provider contradicts itself on whether a membership exists
- Both figures are starting-dose rates; the cost of a titrated dose is published as a ladder rather than a single price
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.